Diphtheria-tetanus-acellular pertussis vaccines

Clinical trials for Diphtheria-tetanus-acellular pertussis vaccines explained in plain language.

Never miss a new study

Get alerted when new Diphtheria-tetanus-acellular pertussis vaccines trials appear

Sign up with your email to follow new studies for Diphtheria-tetanus-acellular pertussis vaccines, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1 Completed 1

One shot in pregnancy could shield babies from whooping cough

Prevention Ongoing

This phase 3 trial will give a single dose of the dTpa vaccine (Boostrix) to 95 healthy Japanese pregnant women between 27 and 37 weeks of pregnancy. The goal is to see if the vaccine triggers strong immunity in the mothers and passes protective antibodies to their babies at birt…

Matched conditions: DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES

Phase 3 • Sponsor: GlaxoSmithKline • Aim: Prevention

Last updated Sep 10, 2026 00:00 UTC

Diphtheria-tetanus-acellular pertussis vaccines

Get alerted when new Diphtheria-tetanus-acellular pertussis vaccines trials appear

One shot in pregnancy could shield babies from whooping cough